BANDARAM

BANDARAM PHARMA PACKTECH financials

Market cap
₹51 Cr

Quarterly results

Q1 FY27: revenue up 195.7%, net profit up 3300.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue7 10 8 8 14 +93%15 +48%26 +209%24 +196%
EBITDA1 1 1 1 0 −59%1 +52%1 +52%2 +146%
Net profit1 -0 0 0 0 −91%0 +1850%0 −40%1 +3300%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −38.6% 1Y

₹20.0₹30.0₹40.0Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹34.99 on 9 Sept 2025 → ₹21.5. High ₹47.52 (1 Dec 2025), low ₹17.34 (20 Aug 2026).

Financials, as filed

Revenue grew 36.0% a year over 2 years, FY24 to FY26. Operating margin narrowed to 4.6%.

Year endingFY24FY25FY26
Revenue₹34 Cr₹37 Cr₹63 Cr
Operating profit₹2 Cr₹3 Cr₹3 Cr
Operating margin6.5%7.7%4.6%
Interest₹1 Cr₹1 Cr₹2 Cr
Depreciation₹1 Cr₹1 Cr₹1 Cr
Net profit₹1 Cr₹1 Cr₹1 Cr
Net margin1.5%2.7%0.8%
Cash from operations₹-4 Cr₹-5 Cr₹-5 Cr
Free cash flow₹-4 Cr₹-5 Cr₹-5 Cr
ROCE9.1%7.7%4.4%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY22FY23FY24FY25FY26
Equity capital₹7 Cr₹3 Cr₹12 Cr₹12 Cr₹18 Cr
Reserves₹-0 Cr₹0 Cr₹0 Cr₹1 Cr₹9 Cr
Borrowings₹0 Cr₹14 Cr₹12 Cr₹22 Cr₹24 Cr
Other liabilities₹0 Cr₹3 Cr₹8 Cr₹6 Cr₹25 Cr
Total liabilities₹7 Cr₹20 Cr₹32 Cr₹40 Cr₹76 Cr
Fixed assets₹3 Cr₹5 Cr₹4 Cr₹4 Cr₹15 Cr
Capital work in progress₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹2 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr
Other assets₹3 Cr₹15 Cr₹26 Cr₹35 Cr₹61 Cr
Total assets₹7 Cr₹20 Cr₹32 Cr₹40 Cr₹76 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, promoters trimmed −12.34 pp while the public added +12.34 pp. The shareholder count grew 4% to 5,103.

Promoters
62.7%
Public
37.3%

Since Jun 2025

  • Promoters −12.34 pp
  • Public +12.34 pp
  • DIIs −0.01 pp

How it drifted, 12 quarters

Over this window promoters fell from 75.0% to 62.7% — −12.3 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Dec '23: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Mar '24: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Jun '24: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Sep '24: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Dec '24: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Mar '25: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Jun '25: Promoters 75.0%, DIIs 0.0%, Public 25.0%.Sep '25: Promoters 75.0%, Public 25.0%.Dec '25: Promoters 62.6%, Public 37.4%.Mar '26: Promoters 62.7%, Public 37.3%.Jun '26: Promoters 62.7%, Public 37.3%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of BANDARAM PHARMA PACKTECH LIMITED above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Deepak Reddy B 35.28%unchanged
Bhandaram Sathyavathi 10.46%unchanged
Prem Sai Reddy B 10.46%unchanged
S. Jhansi 4.37%unchanged
Prajitha Bandaram 2.71%unchanged
L Lalanthika 2.50%unchanged
Sreedar Reddy G 2.23%unchanged
Sanivarapu Navya Reddy 2.08%unchanged
Kolli Suryateja Reddy . 1.86%unchanged
Sapnaa . 1.64%unchanged
Vivek Surana 1.49%unchanged
Sahithi Kolli . 1.34%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse BANDARAM PHARMA PACKTECH LIMITED

Guides on how to read this kind of business and the numbers that matter.